GSK Velu
Healthcare
Coronavirus: Pathology chains wait on the sidelines, device makers gear up
The number of confirmed coronavirus cases (COVID-19), which was declared a pandemic by the World Health Organization (WHO) last week, ......
Healthcare
Explained: How treating medical devices as ‘drugs' will affect companies, investors
From April, all medical devices sold in India will be treated as ‘drugs’. On Tuesday, the central government issued a ......
Healthcare
Trivitron tweaks IPO plan as it weighs exit options for PE investors
Medical devices maker Trivitron Healthcare Pvt. Ltd is considering the possibility of deferring its initial public offering plan and looking ......
Healthcare
Company watch: GSK Velu's Trivitron ramps up revenue, faces working-capital challenges
Trivitron Healthcare Pvt. Ltd, the medical equipment maker founded by serial entrepreneur GSK Velu, doubled the pace of growth in ......
Healthcare
Why hospital chains are still cool to Ayushman Bharat despite higher rates
The Centre's flagship health insurance scheme, which claims to have treated 45 lakh patients within a year of its launch ......
Finance
GSK Velu-backed Stakeboat leads Series E funding round in Dvara KGFS
Financial inclusion services provider Dvara Kshetriya Gramin Financial Services Pvt. Ltd (Dvara KGFS) has raised Rs 97 crore ($14 million) ......
Healthcare
Sector watch: Can India's eye-care chains reverse a revenue slowdown?
When Singapore sovereign wealth fund Temasek Holdings came in as a new investor in Dr Agarwal’s Health Care Ltd earlier ......
Healthcare
Tracing Carlyle's returns from partial exit in Metropolis' upcoming IPO
US-headquartered private equity giant The Carlyle Group appears likely to score modest returns from the sale of a little more ......
Healthcare
GSK Velu on valuations in diagnostics and why localisation is key for services biz
GSK Velu continues to juggle multiple roles. A year ago, he re-entered the diagnostics business by setting up Neuberg Diagnostics ......
Healthcare
How GSK Velu's Trivitron Healthcare has inspired patience among its PE investors
Five years after first betting on a company, private equity investors typically get fidgety and seek an exit. But this ......
